432.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MSFT Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$424.16
Aprire:
$426.185
Volume 24 ore:
29.13M
Relative Volume:
0.79
Capitalizzazione di mercato:
$3.21T
Reddito:
$305.45B
Utile/perdita netta:
$119.26B
Rapporto P/E:
27.09
EPS:
15.9828
Flusso di cassa netto:
$77.41B
1 W Prestazione:
+5.28%
1M Prestazione:
+13.37%
6M Prestazione:
-16.83%
1 anno Prestazione:
+18.02%
Microsoft Corp Stock (MSFT) Company Profile
Nome
Microsoft Corp
Settore
Industria
Telefono
425-882-8080
Indirizzo
ONE MICROSOFT WAY, REDMOND, WA
Compare MSFT vs ORCL, PLTR, CRWD, SNPS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MSFT
Microsoft Corp
|
432.92 | 3.15T | 305.45B | 119.26B | 77.41B | 15.98 |
|
ORCL
Oracle Corp
|
187.50 | 521.05B | 64.08B | 16.40B | -24.74B | 5.5698 |
|
PLTR
Palantir Technologies Inc
|
152.62 | 349.11B | 4.48B | 1.63B | 2.10B | 0.6328 |
|
CRWD
Crowdstrike Holdings Inc
|
466.68 | 114.03B | 4.81B | -181.85M | 1.24B | -0.7398 |
|
SNPS
Synopsys Inc
|
477.26 | 89.57B | 8.00B | 1.10B | 2.28B | 6.4708 |
Microsoft Corp Stock (MSFT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Reiterato | Robert W. Baird | Outperform |
| 2026-04-14 | Reiterato | Mizuho | Outperform |
| 2026-04-14 | Reiterato | Piper Sandler | Overweight |
| 2026-03-25 | Reiterato | UBS | Buy |
| 2026-03-24 | Ripresa | BofA Securities | Buy |
| 2026-02-09 | Downgrade | Melius | Buy → Hold |
| 2026-02-05 | Downgrade | Stifel | Buy → Hold |
| 2026-02-03 | Ripresa | Piper Sandler | Overweight |
| 2026-01-29 | Reiterato | BMO Capital Markets | Outperform |
| 2026-01-29 | Reiterato | Barclays | Overweight |
| 2026-01-29 | Reiterato | Bernstein | Outperform |
| 2026-01-29 | Reiterato | Citigroup | Buy |
| 2026-01-29 | Reiterato | Deutsche Bank | Buy |
| 2026-01-29 | Reiterato | Evercore ISI | Outperform |
| 2026-01-29 | Reiterato | Goldman | Buy |
| 2026-01-29 | Reiterato | JP Morgan | Overweight |
| 2026-01-29 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Reiterato | Piper Sandler | Overweight |
| 2026-01-29 | Reiterato | Robert W. Baird | Outperform |
| 2026-01-29 | Reiterato | Stifel | Buy |
| 2026-01-29 | Reiterato | Wedbush | Outperform |
| 2026-01-29 | Reiterato | Wells Fargo | Overweight |
| 2026-01-26 | Reiterato | Stifel | Buy |
| 2026-01-23 | Reiterato | UBS | Buy |
| 2026-01-21 | Reiterato | Citigroup | Buy |
| 2026-01-21 | Reiterato | Mizuho | Outperform |
| 2026-01-12 | Reiterato | Barclays | Overweight |
| 2026-01-12 | Ripresa | Goldman | Buy |
| 2026-01-08 | Reiterato | Wells Fargo | Overweight |
| 2025-11-18 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-11-14 | Iniziato | Robert W. Baird | Outperform |
| 2025-10-30 | Reiterato | BMO Capital Markets | Outperform |
| 2025-10-27 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2025-10-22 | Reiterato | Citigroup | Buy |
| 2025-10-17 | Reiterato | Mizuho | Outperform |
| 2025-10-06 | Reiterato | Wells Fargo | Overweight |
| 2025-07-31 | Reiterato | BMO Capital Markets | Outperform |
| 2025-07-31 | Reiterato | Barclays | Overweight |
| 2025-07-31 | Reiterato | Bernstein | Outperform |
| 2025-07-31 | Reiterato | BofA Securities | Buy |
| 2025-07-31 | Reiterato | Jefferies | Buy |
| 2025-07-31 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-31 | Reiterato | Mizuho | Outperform |
| 2025-07-31 | Reiterato | Morgan Stanley | Overweight |
| 2025-07-31 | Reiterato | Oppenheimer | Outperform |
| 2025-07-31 | Reiterato | TD Cowen | Buy |
| 2025-07-31 | Reiterato | UBS | Buy |
| 2025-07-31 | Reiterato | Wedbush | Outperform |
| 2025-07-31 | Reiterato | Wells Fargo | Overweight |
| 2025-07-22 | Reiterato | Citigroup | Buy |
| 2025-07-16 | Reiterato | Cantor Fitzgerald | Overweight |
| 2025-07-16 | Reiterato | Mizuho | Outperform |
| 2025-07-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-07-02 | Reiterato | DA Davidson | Buy |
| 2025-06-25 | Reiterato | Wedbush | Outperform |
| 2025-06-11 | Reiterato | Citigroup | Buy |
| 2025-05-01 | Reiterato | BMO Capital Markets | Outperform |
| 2025-05-01 | Reiterato | Barclays | Overweight |
| 2025-05-01 | Reiterato | Evercore ISI | Outperform |
| 2025-05-01 | Reiterato | Goldman | Buy |
| 2025-05-01 | Reiterato | JP Morgan | Overweight |
| 2025-05-01 | Reiterato | Mizuho | Outperform |
| 2025-05-01 | Reiterato | Piper Sandler | Overweight |
| 2025-05-01 | Reiterato | RBC Capital Mkts | Outperform |
| 2025-05-01 | Reiterato | Raymond James | Outperform |
| 2025-05-01 | Reiterato | Scotiabank | Sector Outperform |
| 2025-05-01 | Reiterato | Stifel | Buy |
| 2025-05-01 | Reiterato | Wedbush | Outperform |
| 2025-04-17 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-04-16 | Reiterato | BMO Capital Markets | Outperform |
| 2025-04-16 | Reiterato | Morgan Stanley | Overweight |
| 2025-04-14 | Reiterato | UBS | Buy |
| 2025-04-14 | Reiterato | Wells Fargo | Overweight |
| 2025-03-20 | Iniziato | Scotiabank | Sector Outperform |
| 2025-03-13 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2025-01-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Reiterato | Piper Sandler | Overweight |
| 2024-10-31 | Reiterato | BMO Capital Markets | Outperform |
| 2024-10-10 | Reiterato | Goldman | Buy |
| 2024-10-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-09-23 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-06-10 | Iniziato | New Street | Buy |
| 2024-06-07 | Reiterato | Oppenheimer | Outperform |
| 2024-04-17 | Reiterato | Wells Fargo | Overweight |
| 2024-04-12 | Reiterato | BMO Capital Markets | Outperform |
| 2024-04-11 | Reiterato | Morgan Stanley | Overweight |
| 2024-03-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-01-18 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2023-12-13 | Iniziato | Truist | Buy |
| 2023-12-05 | Iniziato | China Renaissance | Buy |
| 2023-10-26 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2023-10-17 | Iniziato | Loop Capital | Buy |
| 2023-09-25 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2023-09-15 | Iniziato | HSBC Securities | Hold |
| 2023-07-24 | Reiterato | Goldman | Buy |
| 2023-07-24 | Reiterato | Raymond James | Outperform |
| 2023-07-21 | Reiterato | Goldman | Buy |
| 2023-07-19 | Reiterato | Barclays | Overweight |
| 2023-07-19 | Reiterato | BofA Securities | Buy |
| 2023-07-19 | Reiterato | Mizuho | Buy |
| 2023-07-19 | Reiterato | TD Cowen | Outperform |
| 2023-07-19 | Reiterato | Wells Fargo | Overweight |
| 2023-07-17 | Reiterato | Mizuho | Buy |
| 2023-07-14 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-13 | Reiterato | Oppenheimer | Outperform |
| 2023-04-26 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-04-26 | Reiterato | Goldman | Buy |
| 2023-04-26 | Reiterato | Guggenheim | Sell |
| 2023-04-26 | Reiterato | JP Morgan | Overweight |
| 2023-04-26 | Reiterato | Jefferies | Buy |
| 2023-04-26 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2023-04-26 | Reiterato | Mizuho | Buy |
| 2023-04-26 | Reiterato | MoffettNathanson | Market Perform |
| 2023-04-26 | Reiterato | Morgan Stanley | Overweight |
| 2023-04-26 | Reiterato | Oppenheimer | Outperform |
| 2023-04-26 | Reiterato | Piper Sandler | Overweight |
| 2023-04-26 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-26 | Reiterato | Raymond James | Outperform |
| 2023-04-26 | Reiterato | Rosenblatt | Buy |
| 2023-04-26 | Reiterato | Stifel | Buy |
| 2023-04-26 | Reiterato | TD Cowen | Outperform |
| 2023-04-26 | Reiterato | UBS | Neutral |
| 2023-04-26 | Reiterato | Wedbush | Outperform |
| 2023-04-26 | Reiterato | Wells Fargo | Overweight |
| 2023-04-26 | Reiterato | Wolfe Research | Outperform |
| 2023-04-24 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2023-04-21 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-04-20 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2023-04-19 | Reiterato | BofA Securities | Buy |
| 2023-04-19 | Reiterato | Citigroup | Buy |
| 2023-04-19 | Reiterato | Deutsche Bank | Buy |
| 2023-01-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2023-01-05 | Iniziato | DA Davidson | Buy |
| 2023-01-04 | Downgrade | UBS | Buy → Neutral |
| 2022-11-02 | Iniziato | Macquarie | Neutral |
| 2022-10-14 | Reiterato | Morgan Stanley | Overweight |
| 2022-09-30 | Ripresa | Raymond James | Outperform |
| 2022-09-22 | Iniziato | MoffettNathanson | Hold |
| 2022-08-12 | Iniziato | Guggenheim | Neutral |
| 2022-07-27 | Reiterato | BMO Capital Markets | Outperform |
| 2022-07-27 | Reiterato | Citigroup | Buy |
| 2022-07-27 | Reiterato | Cowen | Outperform |
| 2022-07-27 | Reiterato | Deutsche Bank | Buy |
| 2022-07-27 | Reiterato | Stifel | Buy |
| 2022-07-27 | Reiterato | Wedbush | Outperform |
| 2022-07-26 | Iniziato | Itau BBA | Outperform |
| 2022-07-19 | Reiterato | Citigroup | Buy |
| 2022-06-29 | Iniziato | Redburn | Buy |
| 2022-04-27 | Reiterato | BMO Capital Markets | Outperform |
| 2022-04-27 | Reiterato | Deutsche Bank | Buy |
| 2022-04-27 | Reiterato | Evercore ISI | In-line |
| 2022-04-27 | Reiterato | Stifel | Buy |
| 2022-04-27 | Reiterato | Wedbush | Outperform |
| 2022-04-27 | Reiterato | Wolfe Research | Outperform |
| 2022-01-26 | Reiterato | BMO Capital Markets | Outperform |
| 2022-01-26 | Reiterato | Citigroup | Buy |
| 2022-01-26 | Reiterato | Morgan Stanley | Overweight |
| 2022-01-26 | Reiterato | Oppenheimer | Outperform |
| 2022-01-12 | Reiterato | BMO Capital Markets | Outperform |
| 2021-12-22 | Iniziato | SMBC Nikko | Outperform |
| 2021-11-22 | Iniziato | Wells Fargo | Overweight |
| 2021-11-16 | Ripresa | Credit Suisse | Outperform |
| 2021-11-02 | Iniziato | Deutsche Bank | Buy |
| 2021-10-27 | Reiterato | Barclays | Overweight |
| 2021-10-27 | Reiterato | BofA Securities | Buy |
| 2021-10-27 | Reiterato | Cowen | Outperform |
| 2021-10-27 | Reiterato | Credit Suisse | Outperform |
| 2021-10-27 | Reiterato | Goldman | Buy |
| 2021-10-27 | Reiterato | Mizuho | Buy |
| 2021-10-27 | Reiterato | Morgan Stanley | Overweight |
| 2021-10-27 | Reiterato | RBC Capital Mkts | Outperform |
| 2021-10-27 | Reiterato | Stifel | Buy |
| 2021-09-17 | Ripresa | Rosenblatt | Buy |
| 2021-09-14 | Reiterato | Morgan Stanley | Overweight |
| 2021-08-20 | Reiterato | Mizuho | Buy |
| 2021-07-28 | Reiterato | Barclays | Overweight |
| 2021-07-28 | Reiterato | Bernstein | Outperform |
| 2021-07-28 | Reiterato | BofA Securities | Buy |
| 2021-07-28 | Reiterato | Citigroup | Buy |
| 2021-07-28 | Reiterato | Cowen | Outperform |
| 2021-07-28 | Reiterato | Credit Suisse | Outperform |
| 2021-07-28 | Reiterato | Griffin Securities | Buy |
| 2021-07-28 | Reiterato | Mizuho | Buy |
| 2021-07-28 | Reiterato | Morgan Stanley | Overweight |
| 2021-07-28 | Reiterato | Piper Sandler | Overweight |
| 2021-07-28 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-07-28 | Reiterato | Rosenblatt | Buy |
| 2021-07-28 | Reiterato | Stifel | Buy |
| 2021-07-28 | Reiterato | Wolfe Research | Outperform |
| 2021-07-22 | Reiterato | BofA Securities | Buy |
| 2021-07-22 | Reiterato | Citigroup | Buy |
| 2021-07-22 | Reiterato | Cowen | Outperform |
| 2021-07-22 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2021-06-23 | Reiterato | Wedbush | Outperform |
| 2021-05-13 | Iniziato | Rosenblatt | Buy |
| 2021-04-23 | Iniziato | Wolfe Research | Outperform |
| 2021-04-12 | Reiterato | BMO Capital Markets | Outperform |
| 2021-04-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-16 | Ripresa | Credit Suisse | Outperform |
| 2021-03-03 | Ripresa | Citigroup | Buy |
| 2021-01-26 | Ripresa | Raymond James | Strong Buy |
| 2021-01-22 | Iniziato | Goldman | Buy |
| 2020-12-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-12-16 | Ripresa | BofA Securities | Buy |
| 2020-11-24 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-11-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-10-14 | Ripresa | UBS | Buy |
| 2020-07-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-20 | Reiterato | Stifel | Buy |
| 2020-07-15 | Reiterato | BMO Capital Markets | Outperform |
| 2020-07-09 | Reiterato | Wedbush | Outperform |
| 2020-06-24 | Reiterato | Argus | Buy |
| 2020-06-02 | Reiterato | Wells Fargo | Overweight |
| 2020-05-27 | Iniziato | Summit Insights | Buy |
| 2020-04-30 | Reiterato | Griffin Securities | Buy |
| 2020-01-30 | Reiterato | Oppenheimer | Outperform |
| 2020-01-30 | Reiterato | Piper Sandler | Overweight |
| 2020-01-30 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-01-30 | Reiterato | Raymond James | Strong Buy |
| 2020-01-30 | Reiterato | Stifel | Buy |
| 2020-01-30 | Reiterato | Wedbush | Outperform |
| 2020-01-30 | Reiterato | Wells Fargo | Overweight |
Mostra tutto
Microsoft Corp Borsa (MSFT) Ultime notizie
Stellantis accelerates AI strategy through Microsoft partnership - Global Fleet
Rothschild & Co Redburn Adjusts PT on Microsoft to $400 From $450, Maintains Neutral Rating - marketscreener.com
Microsoft Commits $18 Billion to Boost Australia's AI Capabilities - MLQ.ai
Microsoft Needs Copilot to Get Back in the Air - WSJ
Microsoft (MSFT) Stock Gains as Company Commits $18 Billion to Australia AI Infrastructure - CoinCentral
Microsoft Invests $17.9 Billion in Australia for AI and Cloud Ex - GuruFocus
This 8.5% Dividend Trades for 11% Off on the Back of the Private Credit Panic - Investing.com
Modera Wealth Management LLC Sells 7,486 Shares of Microsoft Corporation $MSFT - MarketBeat
Robinhood Asset Management LLC Purchases Shares of 58,520 Microsoft Corporation $MSFT - MarketBeat
Microsoft Corporation $MSFT Position Increased by Vanderbilt University - MarketBeat
South Shore Capital Advisors Takes Position in Microsoft Corporation $MSFT - MarketBeat
Winthrop Advisory Group LLC Buys 1,276 Shares of Microsoft Corporation $MSFT - MarketBeat
Raleigh Capital Management Inc. Purchases 1,235 Shares of Microsoft Corporation $MSFT - MarketBeat
Microsoft 'pause' opportunity to widen CDR buyer base: paper - Quantum Commodity Intelligence
This $114 deal gets you a lifetime of Microsoft Office plus the training you wish you had years ago - Macworld
Microsoft Corporation $MSFT Shares Sold by Brown Shipley& Co Ltd - MarketBeat
AMS Capital Ltda Sells 15,738 Shares of Microsoft Corporation $MSFT - MarketBeat
Microsoft Ramps Up AI Spending Ahead of Earnings with $18B Australia Bet - TipRanks
Microsoft drops $18B on Australia AI infrastructure - The Tech Buzz
Microsoft to invest $18B in Australia to expand AI, cloud and digital infrastructure (MSFT:NASDAQ) - Seeking Alpha
How Microsoft Spooked the Global Carbon Removal Market - Bloomberg.com
Microsoft expands AI footprint in Australia with $18 billion investment - CNBC
Microsoft unveils massive AI investment in Australia - Latest news from Azerbaijan
Microsoft pledges AUD 25 bln investment in Australia by end-2029 - Telecompaper
Microsoft announces $18B investment in Australia's AI infrastructure - Anadolu Ajansı
MSFT (Microsoft Corporation) delivers Q1 2026 EPS beat of 2.6 percent, shares rise 0.6 percent on favorable investor reception.Open Stock Picks - Xã Thanh Hà
Microsoft Announces AUD 25 Billion Investment to Expand Digital Infrastructure and AI Capacity in Australia - marketscreener.com
Microsoft looked at buying Cursor before SpaceX deal: report (MSFT:NASDAQ) - Seeking Alpha
Microsoft to invest $18 billion to expand Australia’s AI capacity by 2029 - MSN
Microsoft Puts A$25 Billion Into Australia’s AI Cloud Buildout - Finimize
Microsoft to invest $18 billion in Australia AI expansion By Investing.com - Investing.com
Microsoft to Invest $18 Billion to Expand Australia's AI Capacity by 2029 -- Update - marketscreener.com
Microsoft Invests $17.9 Billion in Australia to Boost AI Market - GuruFocus
Microsoft Pledges US$ 18 Billion To Build AI Infrastructure In Australia - BusinessToday Malaysia
Microsoft announces record $18 billion investment in Australia to boost AI - marketscreener.com
Microsoft considered Cursor acquisition before SpaceX’s $60B deal- CNBC - Investing.com
Microsoft adds Anthropic AI to find software flaws - Tech in Asia
Microsoft commits $18 billion to build Australian AI capacity - MSN
Microsoft looked at buying Cursor before SpaceX dealCNBC - marketscreener.com
Microsoft looked at buying Cursor before SpaceX deal, sources say - CNBC
Microsoft bets big on AI in Australia with $18 billion investment - Yahoo Finance
Microsoft: to invest A$25 billion in Australia by end of 2029 for AI infrastructure, security, and skills - marketscreener.com
How many employees does Microsoft have in 2026? MSFT’s workforce, locations & layoffs explained - Yahoo Finance Singapore
Microsoft deepens commitment to Australia with A$25 billion investment in AI infrastructure, security, and skills - Microsoft Source
Microsoft Commits $18 Billion to Build Australian AI Capacity - Bloomberg.com
OpenAI–Microsoft Deepen Collaboration on AI-Driven Cybersecurity Defense - TipRanks
Copilot’s agentic capabilities in Word, Excel, and PowerPoint are generally available - Microsoft
9 Important Things to consider before you download Microsoft office or whether to crack Microsoft Office in 2026 - OCNJ Daily
Microsoft Names Daniel Shapero LinkedIn CEO 04/23/2026 - MediaPost
Critical Microsoft vulnerabilities surge as total flaw prevalence declines - SC Media
Microsoft Adds AI Diagnostics to Its Ad Platform - thekeyword.co
Microsoft Corp Azioni (MSFT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):